Dapagliflozin 71921-0421-50
- Manufacturer
- Florida Pharmaceutical Products, Llc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 6, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA211156
Need to source Dapagliflozin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dapagliflozin | 10 mg/1 |
Drug Class
Sodium-Glucose Cotransporter 2 Inhibitor [EPC]Sodium-Glucose Cotransporter 2 Inhibitor [EPC]Sodium-Glucose Transporter 2 Inhibitors [MoA]
Selected Package
71921-0421-50Selected500 TABLET in 1 BOTTLE (71921-421-50)
Other packages for this product(2)
90 TABLET in 1 BOTTLE (71921-421-09)
30 TABLET in 1 BOTTLE (71921-421-33)